AAAAAA

   
Results: 1-12 |
Results: 12
Downregulation of estrogen-metabolizing 17 beta-hydroxysteroid dehydrogenase type 2 expression correlates inversely with Ki67 proliferation marker incolon-cancer development
Authors: Oduwole, OO Isomaa, VV Nokelainen, PA Stenback, F Vihko, PT
Citation: Oo. Oduwole et al., Downregulation of estrogen-metabolizing 17 beta-hydroxysteroid dehydrogenase type 2 expression correlates inversely with Ki67 proliferation marker incolon-cancer development, INT J CANC, 97(1), 2002, pp. 1-6
Morphometric characteristics of cell proliferation and p53 expression in development of experimentally induced respiratory tumors
Authors: Laitakari, J Harrison, D Stenback, F
Citation: J. Laitakari et al., Morphometric characteristics of cell proliferation and p53 expression in development of experimentally induced respiratory tumors, ANAL QUAN C, 23(4), 2001, pp. 273-286
Survival of human ovarian follicles from fetal to adult life: Apoptosis, apoptosis-related proteins, and transcription factor GATA-4
Authors: Vaskivuo, TE Anttonen, M Herva, R Billig, H Dorland, M te Velde, ER Stenback, F Heikinheimo, M Tapanainen, JS
Citation: Te. Vaskivuo et al., Survival of human ovarian follicles from fetal to adult life: Apoptosis, apoptosis-related proteins, and transcription factor GATA-4, J CLIN END, 86(7), 2001, pp. 3421-3429
Adenoviral expression of vascular endothelial growth factor-C induces lymphangiogenesis in the skin
Authors: Enholm, B Karpanen, T Jeltsch, M Kubo, H Stenback, F Prevo, R Jackson, DG Yla-Herttuala, S Alitalo, K
Citation: B. Enholm et al., Adenoviral expression of vascular endothelial growth factor-C induces lymphangiogenesis in the skin, CIRCUL RES, 88(6), 2001, pp. 623-629
Apoptosis and apoptosis-related proteins in human endometrium
Authors: Vaskivuo, TE Stenback, F Karhumaa, P Risteli, J Dunkel, L Tapanainen, JS
Citation: Te. Vaskivuo et al., Apoptosis and apoptosis-related proteins in human endometrium, MOL C ENDOC, 165(1-2), 2000, pp. 75-83
Loss of heterozygosity at chromosomes 3, 6, 8, 11, 16, and 17 in ovarian cancer: correlation to clinicopathological variables
Authors: Launonen, V Mannermaa, A Stenback, F Kosma, VM Puistola, U Huusko, P Anttila, M Bloigu, R Saarikoski, S Kauppila, A Winqvist, R
Citation: V. Launonen et al., Loss of heterozygosity at chromosomes 3, 6, 8, 11, 16, and 17 in ovarian cancer: correlation to clinicopathological variables, CANC GENET, 122(1), 2000, pp. 49-54
TGF-beta isoforms are differentially expressed in increasing malignant grades of HaCaT keratinocytes, suggesting separate roles in skin carcinogenesis
Authors: Gold, LI Jussila, T Fusenig, NE Stenback, F
Citation: Li. Gold et al., TGF-beta isoforms are differentially expressed in increasing malignant grades of HaCaT keratinocytes, suggesting separate roles in skin carcinogenesis, J PATHOLOGY, 190(5), 2000, pp. 579-588
The extracellular matrix in skin tumor development - a morphological study
Authors: Stenback, F Makinen, MJ Jussila, T Kauppila, S Risteli, J Talve, L Risteli, L
Citation: F. Stenback et al., The extracellular matrix in skin tumor development - a morphological study, J CUT PATH, 26(7), 1999, pp. 327-338
Characterization of type I collagen synthesis and maturation in uterine carcinosarcomas
Authors: Kauppila, S Stenback, F Kacinski, BM Carcangiu, MWL Risteli, J Risteli, L
Citation: S. Kauppila et al., Characterization of type I collagen synthesis and maturation in uterine carcinosarcomas, CANCER, 86(7), 1999, pp. 1299-1306
Cross linked telopeptides of type I and III collagens in malignant ovariantumours in vivo
Authors: Kauppila, S Bode, MK Stenback, F Risteli, L Risteli, J
Citation: S. Kauppila et al., Cross linked telopeptides of type I and III collagens in malignant ovariantumours in vivo, BR J CANC, 81(4), 1999, pp. 654-661
Elevated serum inhibin and tumor-associated trypsin inhibitor concentrations in a young woman with dysgerminoma of the ovary
Authors: Santala, M Burger, H Ruokonen, A Stenback, F Kauppila, A
Citation: M. Santala et al., Elevated serum inhibin and tumor-associated trypsin inhibitor concentrations in a young woman with dysgerminoma of the ovary, GYNECOL ONC, 71(3), 1998, pp. 465-468
Chromosome 11q22.3-q25 LOH in ovarian cancer: Association with a more aggressive disease course and involved subregions
Authors: Launonen, V Stenback, F Puistola, U Bloigu, R Huusko, P Kytola, S Kauppila, A Winqvist, R
Citation: V. Launonen et al., Chromosome 11q22.3-q25 LOH in ovarian cancer: Association with a more aggressive disease course and involved subregions, GYNECOL ONC, 71(2), 1998, pp. 299-304
Risultati: 1-12 |